Clinical Trials
26 trialsLEVEL
Grupo Espanol de Tumores Neuroendocrinos
iCaRe2
University of Nebraska
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
DuTOC
Dutch Society of Physicians for Pulmonology and Tuberculosis
FAPI PET RDRC
Jonsson Comprehensive Cancer Center
Molecular Analysis of Thoracic Malignancies
Stanford University
PARTNER
Azienda Ospedaliera di Padova
Molecular Analysis and Treatment Options of Thymic Malignancies
Shanghai Chest Hospital
iTHYM
Sun Yat-sen University
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Xiangya Hospital of Central South University
TOGA
University of Wisconsin, Madison
Cardiac MRI Biomarker Testing (GCC 1618)
University of Maryland, Baltimore
Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors
Augusta University
Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin
M.D. Anderson Cancer Center
ESIMRT
Duke University
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies
M.D. Anderson Cancer Center
Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma
Georgetown University
A Phase 2 Study of Amrubicin in Relapsed or Refractory Thymic Malignancies
Stanford University
A Phase II Study of Palbociclib for Recurrent or Refractory Advanced Thymic Epithelial Tumor
Samsung Medical Center
MEN1
Jersey Shore University Medical Center
Prospective Study of Stereotactic Body Radiation Therapy for Thymoma Inoma: Therapeutic Effect and Toxicity Assessment
Third Military Medical University
Neoadjuvant Chemotherapy for Locally Advanced Thymic Cancer
Samsung Medical Center
B-Receptor Signaling in Cardiomyopathy
Stanford University
Heated Chemotherapy for Cancers That Have Spread to the Chest Cavity
St. Luke's-Roosevelt Hospital Center
A Study to Test the Safety and Efficacy of Erlotinib Plus Bevacizumab to Treat Advanced Thymoma and Thymic Cancer
Indiana University
HIDONET
Federico II University